Literature DB >> 9395357

Distinguishing baboon cytomegalovirus from human cytomegalovirus: importance for xenotransplantation.

M G Michaels1, D J Alcendor, K St George, C R Rinaldo, G D Ehrlich, M J Becich, G S Hayward.   

Abstract

The severe shortage of human organs for transplantation is the driving force behind xenotransplant research. Nonhuman primates, particularly baboons, are potential sources of organs and tissues. Human cytomegalovirus (HCMV) is the most common donor-associated infection after allotransplantation. Baboon cytomegalovirus (BCMV) is endemic in baboon populations and therefore is a potential cause of donor-associated disease after xenotransplantation. Accordingly, the ability for BCMV to grow in human cells was determined and a sensitive method to distinguish BCMV from HCMV was developed. Human fibroblasts were permissive for BCMV, isolates exhibited cytopathology characteristic of HCMV, and herpesvirus-like virions were observed by electron microscopy. BCMV and HCMV could be distinguished by restriction fragment length polymorphism patterns and by polymerase chain reaction with primers targeting the BCMV major immediate-early gene promoter. These methods can be used to evaluate BCMV pathogenicity in laboratory and clinical xenotransplant trials.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9395357     DOI: 10.1086/514144

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Simian homologues of human gamma-2 and betaherpesviruses in mandrill and drill monkeys.

Authors:  V Lacoste; P Mauclere; G Dubreuil; J Lewis; M C Georges-Courbot; J Rigoulet; T Petit; A Gessain
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation.

Authors:  M G Michaels; F J Jenkins; K St George; M A Nalesnik; T E Starzl; C R Rinaldo
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Activation of cytomegalovirus in pig-to-primate organ xenotransplantation.

Authors:  Nicolas J Mueller; Rolf N Barth; Shin Yamamoto; Hiroshi Kitamura; Clive Patience; Kazuhiko Yamada; David K C Cooper; David H Sachs; Amitinder Kaur; Jay A Fishman
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  The road to the first FDA-approved genetically engineered pig heart transplantation into human.

Authors:  Avneesh K Singh; Bartley P Griffith; Corbin E Goerlich; David Ayares; Muhammad M Mohiuddin
Journal:  Xenotransplantation       Date:  2022-09-20       Impact factor: 3.788

5.  Adenovirus and herpesvirus diversity in free-ranging great apes in the Sangha region of the Republic Of Congo.

Authors:  Tracie A Seimon; Sarah H Olson; Kerry Jo Lee; Gail Rosen; Alain Ondzie; Kenneth Cameron; Patricia Reed; Simon J Anthony; Damien O Joly; William B Karesh; Denise McAloose; W Ian Lipkin
Journal:  PLoS One       Date:  2015-03-17       Impact factor: 3.240

Review 6.  Reduction of the survival time of pig xenotransplants by porcine cytomegalovirus.

Authors:  Joachim Denner
Journal:  Virol J       Date:  2018-11-08       Impact factor: 4.099

7.  Distribution of Porcine Cytomegalovirus in Infected Donor Pigs and in Baboon Recipients of Pig Heart Transplantation.

Authors:  Uwe Fiebig; Jan-Michael Abicht; Tanja Mayr; Matthias Längin; Andrea Bähr; Sonja Guethoff; Almuth Falkenau; Eckhard Wolf; Bruno Reichart; Tomoyuki Shibahara; Joachim Denner
Journal:  Viruses       Date:  2018-02-06       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.